Cognitive Behavioral Psychotherapy after COVID-19: Opportunities and Prospects

This article reviews domestic and foreign studies on cognitive behavioral therapy techniques in treating cognitive disorders in former COVID-19 patients. Coronavirus-induced cognitive disorders include damage to the nervous system as a result of respiratory distress syndrome, cytokine storm, cerebral vascular thrombosis, direct exposure to SARS-Cov2, and inadequate immune response. Concomitant mental illnesses include autistic disorders, dementia, cognitive decline, eating disorders, suicidal behavior, anxiety, depression, post-traumatic stress, insomnia, etc. Diagnostic methods usually take into account a complex violation of mental activities, e.g., short memory span, attention deficiency, slow thinking, and various affective disorders. As a result, diagnostic methods can be divided into several areas: neuropsychological diagnostics of cognitive functions (MMSE, MOCA, FAB), identification of inadequate attitudes and behavior (WCQ, SPB, DAS), identification of violations of daily activity (The Barthel Scale), identification of psychological and psychiatric issues (Hospital Anxiety and Depression Scale, State-Trait Anxiety Inventory, Hamilton Rating Scale for Depression). Psychological care for former COVID-19 patients relies on some basic principles. Cognitive behavioral psychotherapy techniques aim at correcting cognitive distortions, teaching relaxation and self-regulation, improving problem-solving skills, and restoring cognitive functions. 

1. Ostroumova T. M., Chernousov P. A., Kuznetsov I. V. Cognitive impairment in COVID-19 survivors. Nevrologiya, Neiropsikhiatriya, Psikhosomatika, 2021, 13(1): 126–130. (In Russ.) https://doi.org/10.14412/2074-2711-2021-1-126-130

2. Alonzi S., La Torre A., Silverstein M. W. The psychological impact of preexisting mental and physical health conditions during the COVID-19 pandemic. Psychological Trauma: Theory, Research, Practice, and Policy. 2020, 12(S1): 236–238. https://doi.org/10.1037/tra0000840

3. Goularte J. F., Serafim S. D., Colombo R., Hogg B., Caldieraro M. A., Rosa A. R. COVID-19 and mental health in Brazil: psychiatric symptoms in the general population. Journal of Psychiatric Research, 2021, 132: 32–37. https://doi.org/10.1016/j.jpsychires.2020.09.021

4. Solodukhin A. V., Seryy A. V., Yanitskiy M. S., Trubnikova O. A. Cognitive behavioral therapy: an option for changing internal picture of disease in patients with coronary artery disease. Fundamental and Clinical Medicine, 2017, 2(1): 84–90. (In Russ.)

5. Jaywant A., Vanderlind W. M., Alexopoulos G. S., Fridman C. B., Perlis R. H., Gunning F. M. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology, 2021, 46(13): 2235–2240. https://doi.org/10.1038/s41386-021-00978-8

6. Rabinovitz B., Jaywant A., Fridman C. B. Neuropsychological functioning in severe acute respiratory disorders caused by the coronavirus: implications for the current COVID-19 pandemic. Clinical Neuropsychologist, 2020, 34(7-8): 1453–1479. https://doi.org/10.1080/13854046.2020.1803408

7. Abdelghani M., Atwa S. A., Said A., Zayed N. E., Abdelmoaty A. A., Hassan M. S. Cognitive after-effects and associated correlates among post-illness COVID-19 survivors: a cross-sectional study, Egypt. Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2022, 58(1). https://doi.org/10.1186/s41983-022-00505-6

8. Ferrucci R., Dini M., Rosci C., Capozza A., Groppo E., Reitano M. R., Allocco E., Poletti B., Brugnera A., Bai F., Monti A., Ticozzi N., Silani V., Centanni S., D’Arminio Monforte A., Tagliabue L., Priori A. One‐year cognitive follow‐up of COVID‐19 hospitalized patients. European Journal of Neurology, 2022, 29(7): 2006–2014. https://doi.org/10.1111/ene.15324

9. Ran L., Wang W., Ai M., Kong Y., Chen J., Kuang L. Psychological resilience, depression, anxiety, and somatization symptoms in response to COVID-19: a study of the general population in China at the peak of its epidemic. Social Science & Medicine, 2020, 262. https://doi.org/10.1016/j.socscimed.2020.113261

10. Efremova D. N. Neuropsychological rehabilitation of cognitive functions of popular people during isolation on coronavirus infection. Eurasian Union of Scientists, 2020, (6-3): 50–53. (In Russ.) https://doi.org/10.31618/ESU.2413-9335.2020.3.75.841

11. Boldrini M., Canoll P. D., Klein R. S. How COVID-19 affects the brain. JAMA psychiatry, 2021, 78(6): 682–683. https://doi.org/10.1001/jamapsychiatry.2021.0500

12. Cao W., Hou G., Han M., Xu X., Dong J., Zheng J. The psychological impact of the COVID-19 epidemic on college students in China. Psychiatry research, 2020, 287. https://doi.org/10.1016/j.psychres.2020.112934

13. Lipowski Z. J. Somatization: the experience and communication of psychological distress as somatic symptoms. Psychotherapy and Psychosomatics, 1987, 47(3-4): 160–167. https://doi.org/10.1159/000288013

14. Liyanage-Don N. A., Cornelius T., Sanchez J. E., Trainor A., Moise N., Wainberg M., Kronish I. M. Psychological distress, persistent physical symptoms, and perceived recovery after COVID-19 illness. Journal of General Internal Medicine, 2021, 36(8): 2525–2527. https://doi.org/10.1007/s11606-021-06855-w

15. Cheng P., Casement M. D., Kalmbach D. A., Castelan A. C., Drake C. L. Digital cognitive behavioral therapy for insomnia promotes later health resilience during the coronavirus disease 19 (COVID-19) pandemic. Sleep, 2021, 44(4). https:// doi.org/10.1093/sleep/zsaa258

16. Kopelovich S. L., Turkington D. Remote CBT for psychosis during the COVID-19 pandemic: challenges and opportunities. Community Mental Health Journal, 2021, 57(1): 30–34. https://doi.org/10.1007/s10597-020-00718-0

17. Li J., Li X., Jiang J., Xu X., Wu J., Xu Y., Lin X., Hall J., Xu H., Xu J., Xu X. The effect of cognitive behavioral therapy on depression, anxiety, and stress in patients with COVID-19: a randomized controlled trial. Frontiers in psychiatry, 2020, 11. https://doi.org/10.3389/fpsyt.2020.580827

18. Murphy R., Calugi S., Cooper Z., Dalle Grave R. Challenges and opportunities for enhanced cognitive behaviour therapy (CBT-E) in light of COVID-19. Cognitive Behaviour Therapist, 2020, 13. https://doi.org/10.1017/S1754470X20000161

19. Song J., Jiang R., Chen N., Qu W., Liu D., Zhang M., Fan H., Zhao Y., Tan S. Self-help cognitive behavioral therapy application for COVID-19-related mental health problems: a longitudinal trial. Asian journal of psychiatry, 2021, 60. https://doi.org/10.1016/j.ajp.2021.102656

20. Wright J. H., Caudill R. Remote treatment delivery in response to the COVID-19 pandemic. Psychotherapy and Psychosomatics, 2020, 89(3): 130–132. https://doi.org/10.1159/000507376

21. Amanat M., Rezaei N., Roozbeh M., Shojaei M., Tafakhori A., Zoghi A., Darazam I. A., Salehi M., Karimialavijeh E., Lima B. S., Garakani A., Vaccaro A., Ramezani M. Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study. BMC neurology, 2021, 21(1). https://doi.org/10.1186/s12883-021-02152-5

22. Karadaş Ö., Öztürk B., Sonkaya A. R. A prospective clinical study of detailed neurological manifestations in patients with COVID-19. Neurological Sciences, 2020, 41(8): 1991–1995. https://doi.org/10.1007/s10072-020-04547-7

23. Koh J. S., De Silva D. A., Quek A. M. L., Chiew H. J., Tu T. M., Seet C. Y. H., Hoe R. H. M., Saini M., Hui A. C.-F., Angon J., Ker J. R., Yong M. H., Goh Y., Yu W.-Y., Lim T. C. C., Tan B. Y. Q., Ng K. W. P., Yeo L. L. L., Pang Y. Z., Prakash K. M., Ahmad A., Thomas T., Lye D. C. B., Tan K., Umapathi T. Neurology of COVID-19 in Singapore. Journal of the Neurological Sciences, 2020, 418. https://doi.org/10.1016/j.jns.2020.117118

24. Liotta E. M., Batra A., Clark J. R., Shlobin N. A., Hoffman S. C., Orban Z. S., Koralnik I. J. Frequent neurologic manifestations and encephalopathy‐associated morbidity in Covid‐19 patients. Annals of Clinical and Translational Neurology, 2020, 7(11): 2221–2230. https://doi.org/10.1002/acn3.51210

25. Liguori C., Pierantozzi M., Spanetta M., Sarmati L., Cesta N., Iannetta M., Ora J., Mina G. G., Puxeddu E., Balbi O., Pezzuto G., Magrini A., Rogliani P., Andreoni M., Mercuri N. B. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain, Behavior, and Immunity, 2020, 88: 11–16. https://doi.org/10.1016/j.bbi.2020.05.037

26. Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P., Cuapio A., Villapol S. More than 50 longterm effects of COVID-19: a systematic review and meta-analysis. Scientific reports, 2021, 11(1). https://doi.org/10.21203/rs.3.rs-266574/v1

27. Ma M., Shi Z., Wu H., Ma X. Clinical implications of panic attack in Chinese patients with somatoform disorders. Journal of Psychosomatic Research, 2021, 146. https://doi.org/10.1016/j.jpsychores.2021.110509

28. Nguyen N. N., Hoang V. T., Dao T. L., Dudouet P., Eldin C., Gautret P. Clinical patterns of somatic symptoms in patients suffering from post-acute long COVID: a systematic review. European Journal of Clinical Microbiology & Infectious Diseases, 2022, 41(4): 515–545. https://doi.org/10.1007/s10096-022-04417-4

29. Nochaiwong S., Ruengorn C., Thavorn K., Hutton B., Awiphan R., Phosuya C., Ruanta Y., Wongpakaran N., Wongpakaran T. Global prevalence of mental health issues among the general population during the coronavirus disease-2019 pandemic: a systematic review and meta-analysis. Scientific Reports, 2021, 11(1). https://doi.org/10.1038/s41598-021-89700-8

30. Sampaio Rocha-Filho P. A., Albuquerque P. M., Carvalho L. C. L. S., Dandara Pereira Gama M., Magalhães J. E. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study. Journal of headache and pain, 2022, 23(1). https://doi.org/10.1186/s10194-021-01367-8

31. Fan S., Xiao M., Han F., Xia P., Bai X., Chen H., Zhang H., Ding X., Zhao H., Zhao J., Sun X., Jiang W., Wang C., Cao W., Guo F., Tian R., Gao P., Wu W., Ma J., Wu D., Liu Z., Zhou X., Wang J., Guan T., Qin Y., Li T., Xu Y., Zhang D., Chen Y., Xie J., Li Y., Yan X., Zhu Y., Peng B., Cui L., Zhang S., Guan H. Neurological manifestations in critically ill patients with COVID-19: a retrospective study. Frontiers in neurology, 2020, 11. https://doi.org/10.3389/fneur.2020.00806

32. Filatov A., Sharma P., Hindi F., Espinosa P. S. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus, 2020, 12(3). https://doi.org/10.7759/cureus.7352

33. Fotuhi M., Mian A., Meysami S., Raji C. A. Neurobiology of COVID-19. Journal of Alzheimer's Disease, 2020, 76(1): 3–19. https://doi.org/10.3233/JAD-200581

34. Li T., Lu H., Zhang W. Clinical observation and management of COVID-19 patients. Emerging Microbes & Infections, 2020, 9(1): 687–690. https://doi.org/10.1080/22221751.2020.1741327

35. Mao L., Wang M., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., Li Y., Jin H., Hu B. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. MedRxiv, 2020. https://doi.org/10.1101/2020.02.22.20026500

36. Nersesjan V., Amiri M., Lebech A.-M., Roed C., Mens H., Russell L., Fonsmark L., Berntsen M., Sigurdsson S. T., Carlsen J., Langkilde A. R., Martens P., Lund E. L., Hansen K., Jespersen B., Folke M., N., Meden P., Hejl A.-M., Wamberg C., Benros M. E., Kondziella D. Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up. Journal of Neurology, 2021, 268(9): 3086–3104. https://doi.org/10.1007/s00415-020-10380-x

37. Ritchie K., Chan D., Watermeyer T. The cognitive consequences of the COVID-19 epidemic: collateral damage? Brain Communications, 2020, 2(2). https://doi.org/10.1093/braincomms/fcaa069

38. Zhou F., Yu, T., Du R., Fan G., Liu Y., Liu Z., Xiang J, Wang Y., Song B., Gu X., Guan L., Wei Y., Li H., Wu X., Xu J., Tu S., Zhang Y., Chen H., Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 2020, 395(10229): 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3

39. Пизова Н. В., Пизов Н. А., Пизов А. В. Когнитивные нарушения у лиц, перенесших COVID-19. Медицинский совет. 2021. № 4. С. 69–77. [Pizova N. V., Pizov N. A., Pizov A. V. Cognitive impairment in COVID-19 survivors. Meditsinskiy Sovet, 2021, (4): 69–77. (In Russ.)] https://doi.org/10.21518/2079-701X-2021-4-69-77

40. Rogers J. P., Chesney E., Oliver D., Pollak T. A., McGuire P., Fusar-Poli P., Zandi M. S., Lewis G., David A. S. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. The Lancet Psychiatry, 2020, 7(7): 611–627. https://doi.org/10.1016/S2215-0366(20)30203-0

41. Crunfli F., Carregari V. C., Veras F. P., Vendramini P. H., Valença A. G. F. et al. SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability. MedRxiv, 2021. https://doi.org/10.1101/2020.10.09.20207464

42. Helms J., Kremer S., Merdji H., Clere-Jehl R., Schenck M., Kummerlen C., Collange O., Boulay C., Fafi-Kremer S., Ohana M., Anheim M., Meziani F. Neurologic features in severe SARS-CoV-2 infection. New England Journal of Medicine, 2020, 382(23): 2268–2270. https://doi.org/10.1056/NEJMc2008597

43. Moreno C., Wykes T., Galderisi S., Nordentoft M., Crossley N., Jones N., Cannon M., Correll C., Byrne L., Carr S., Chen E. Y. H., Gorwood P., Johnson S., Kärkkäinen H., Krystal J. H., Lee J., Lieberman J., López-Jaramillo C., Männikkö M., Phillips M. R., Uchida H., Vieta E., Vita A., Arango C. How mental health care should change as a consequence of the COVID-19 pandemic. The Lancet Psychiatry, 2020, 7(9): 813–824. https://doi.org/10.1016/S2215-0366(20)30307-2

44. Altman M. T., Knauert M. P., Pisani M. A. Sleep disturbance after hospitalization and critical illness: a systematic review. Annals of the American Thoracic Society, 2017, 14(9): 1457–1468. https://doi.org/10.1513/AnnalsATS.201702-148SR

45. Bianchetti A., Rozzini R., Bianchetti L., Coccia F., Guerini F., Trabucchi M. Dementia clinical care in relation to COVID-19. Current Treatment Options in Neurology, 2022, 24(1). 1–15. https://doi.org/10.1007/s11940-022-00706-7

46. Bo H. X., Li W., Yang Y., Wang Y., Zhang Q., Cheung T., Wu X., Xiang Y.-T.Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China. Psychological Medicine, 2021, 51(6): 1052–1053. https://doi.org/10.1017/S0033291720000999

47. Cénat J. M., Blais-Rochette C., Kokou-Kpolou C. K., Noorishad P.-G., Mukunzi J. N., McIntee S.-E., Dalexis R. D., Goulet M.-A., Labelle R. P. Prevalence of symptoms of depression, anxiety, insomnia, posttraumatic stress disorder, and psychological distress among populations affected by the COVID-19 pandemic: a systematic review and meta-analysis. Psychiatry Research, 2021, 295. https://doi.org/10.1016/j.psychres.2020.113599

48. Fernández‐Aranda F., Casas M., Claes L., Bryan D. C., Favaro A., Granero R., Gudiol C., Jiménez-Murcia S., Karwautz A., Le Grange D., Menchón J. M., Tchanturia K., Treasure J. COVID‐19 and implications for eating disorders. European Eating Disorders Review, 2020, 28(3): 239–245. https://doi.org/10.1002/erv.2738

49. Hampshire A., Trender W., Chamberlain S. R., Jolly A. E., Grant J. E., Patrick F., Mazibuko N., Williams S. C. R., Barnby J. M., Hellyer P., Mehta M. A. Cognitive deficits in people who have recovered from COVID-19. eClinicalMedicine, 2021, 39. https://doi.org/10.1016/j.eclinm.2021.101044

50. Holmes E. A., O'Connor R. C., Perry V. H., Tracey I., Wessely S., Arseneault L., Ballard C., Christensen H., Cohen Silver R., Everall I., Ford T., John A., Kabir T., King K., Madan I., Michie S., Przybylski A. K., Shafran R., Sweeney A., Worthman C. M., Yardley L., Cowan K., Cope C., Hotopf M., Bullmore E. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. The Lancet Psychiatry, 2020, 7(6): 547–560. https://doi.org/10.1016/S2215-0366(20)30168-1

51. Kaseda E. T., Levine A. J. Post-traumatic stress disorder: a differential diagnostic consideration for COVID-19 survivors. Clinical Neuropsychologist, 2020, 34(7-8): 1498–1514. https://doi.org/10.1080/13854046.2020.1811894

52. Lee S. H., Shin H.-S., Park H. Y., Kim J. L., Lee J. J., Lee H., Won S.-D., Han W. Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in Middle East respiratory syndrome survivors. Psychiatry Investigation, 2019, 16(1): 59–64. https://doi.org/10.30773/pi.2018.10.22.3

53. Manera M. R., Fiabane E., Pain D., Aiello E. N., Radici A., Ottonello M., Padovani M., Wilson B. A., Fish J., Pistarini C. Clinical features and cognitive sequelae in COVID-19: a retrospective study on N=152 patients. Neurological Sciences, 2022, 43(1): 45–50. https://doi.org/10.1007/s10072-021-05744-8

54. Patterson P. H. Maternal infection and immune involvement in autism. Trends in molecular medicine, 2011, 17(7): 389–394. https://doi.org/10.1016/j.molmed.2011.03.001

55. Rodgers R. F., Lombardo C., Cerolini S., Franko D. L., Omori M., Fuller-Tyszkiewicz M., Linardon J., Courtet P., Guillaume S. The impact of the COVID‐19 pandemic on eating disorder risk and symptoms. International Journal of Eating Disorders, 2020, 53(7): 1166–1170. https://doi.org/10.1002/eat.23318

56. Steinman G. COVID-19 and autism. Medical Hypotheses, 2020, 142. https://doi.org/10.1016/j.mehy.2020.109797

57. Toniolo S., Scarioni M., Di Lorenzo F., Hort J., Georges J., Tomic S., Nobili F., Frederiksen K. S., Bonanni L. Dementia and COVID-19, a bidirectional liaison: risk factors, biomarkers, and optimal health care. Journal of Alzheimer's Disease, 2021, 82(3): 883–898. https://doi.org/10.3233/JAD-210335

58. Wilson B. A., Betteridge S., Fish J. Neuropsychological consequences of Covid-19. Neuropsychological Rehabilitation, 2020, 30(9): 1625–1628. https://doi.org/10.1080/09602011.2020.1808483

59. Barylnik S. N. Studying the impact of the Covid-19 pandemic on cognitive functions. Innovatsii. Nauka. Obrazovanie, 2022, (49): 1582–1592. (In Russ.)

60. Raspopova N. I., Eshimbetova S. Z., Dzhamantaeva M. Sh., Suleimenova A. A., Aimakova I. M., Kulamkadyrova N. S. Mental disorders in Covid-19 survivors and methods of therapy. Vestnik Kazahskogo Nacional'nogo medicinskogo universiteta, 2021, (4): 228–234. (In Russ.)

61. Abreu L., Koebach A., Díaz O., Carleial S., Hoeffler A., Stojetz W., Freudenreich H., Justino P., Brück T. Life with corona: increased gender differences in aggression and depression symptoms due to the COVID-19 pandemic burden in Germany. Frontiers in Psychology, 2021, 12. https://doi.org/10.3389/fpsyg.2021.689396

62. Biermann M., Vonderlin R., Mier D., Witthöft M., Bailer J. Predictors of psychological distress and coronavirus fears in the first recovery phase of the coronavirus disease 2019 pandemic in Germany. Frontiers in Psychology, 2021, 12. https://doi.org/10.3389/fpsyg.2021.678860

63. Carda S., Invernizzi M., Bavikatte G., Bensmaïl D., Bianchi F., Deltombe T., Draulans N., Esquenazi A., Francisco G. E., Gross R., Jacinto L. J., Moraleda Pérez S., O'Dell M. W., Reebye R., Verduzco-Gutierrez M., Wissel J., Molteni F. The role of physical and rehabilitation medicine in the COVID-19 pandemic: the clinician's view. Annals of Physical and Rehabilitation Medicine, 2020, 63(6): 554–556. https://doi.org/10.1016/j.rehab.2020.04.001

64. Gattinoni L., Coppola S., Cressoni M., Busana M., Rossi S., Chiumello D. COVID-19 does not lead to a "typical" acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine, 2020, 201(10): 1299–1300. https://doi.org/10.1164/rccm.202003-0817LE

65. Navas-Blanco J. R., Dudaryk R. Management of respiratory distress syndrome due to COVID-19 infection. BMC Anesthesiology, 2020, 20(1). https://doi.org/10.1186/s12871-020-01095-7

66. Pistarini C., Fiabane E., Houdayer E., Vassallo C., Manera M. R., Alemanno F.Cognitive and emotional disturbances due to COVID-19: an exploratory study in the rehabilitation setting. Frontiers in Neurology, 2021, 12. https://doi.org/10.3389/fneur.2021.643646

67. Vannorsdall T. D., Brigham E., Fawzy A., Raju S., Gorgone A., Pletnikova A., Lyketsos C. G., Parker A. M., Oh E. S. Cognitive dysfunction, psychiatric distress, and functional decline after COVID-19. Journal of the Academy of Consultation-Liaison Psychiatry, 2022, 63(2): 133–143. https://doi.org/10.1016/j.jaclp.2021.10.006

68. Aiello E. N., Fiabane E., Manera M. R., Radici A., Grossi F., Ottonello M., Pain D., Pistarini C. Screening for cognitive sequelae of SARS-CoV-2 infection: a comparison between the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA). Neurological Sciences, 2022, 43(1): 81–84. https://doi.org/10.1007/s10072-021-05630-3

69. Ahmed M. Z., Ahmed O., Aibao Z., Hanbin S., Siyu L., Ahmad A. Epidemic of COVID-19 in China and associated psychological problems. Asian Journal of Psychiatry, 2020, 51. https://doi.org/10.1016/j.ajp.2020.102092

70. Dadov I. T., Malkarova R. Kh., Dadov I. T., Miziev O. A., Gelyastanov I. Kh. Psychological aspects of rehabilitation after a new coronovirus infection. International Journal of Medicine and Psychology, 2022, 5(2) 84–88. (In Russ.)

71. Achabaeva A. B., Teuvazhukova D. A., Kuchmezova F. A., Kalmykov I. A., Gelyastanov I. Kh. Medical rehabilitation and sanatorium-resort treatment of patients with new coronavirus infection COVID-19. Pharmateca, 2021, 28(10): 99–102. (In Russ.) https://doi.org/10.18565/pharmateca.2021.10.99-W2

72. Cénat J. M., Dalexis R. D., Kokou-Kpolou C. K., Mukunzi J. N., Rousseau C. Social inequalities and collateral damages of the COVID-19 pandemic: when basic needs challenge mental health care. International Journal of Public Health, 2020, 65(6): 717–718. https://doi.org/10.1007/s00038-020-01426-y

73. Hao F., Tan W., Jiang L., Zhang L., Zhao X., Zou Y., Hu Y., Luo X., Jiang X., McIntyre R. S., Tran B., Sun J., Zhang Z., Ho R., Ho C., Tam W. Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry. Brain, Behavior, and Immunity, 2020, 87: 100–106. https://doi.org/10.1016/j.bbi.2020.04.069

74. Shevlin M., Nolan E., Owczarek M., McBride O., Murphy J., Gibson M. J., Hartman T. K., Levita L., Mason L., Martinez A. P., McKay R., Stocks T. V. A., Bennett K. M., Hyland P., Bentall R. P. COVID‐19‐related anxiety predicts somatic symptoms in the UK population. British Journal of Health Psychology, 2020, 25(4): 875–882. https://doi.org/10.1111/bjhp.12430

75. Wright J. H., Mishkind M., Eells T. D., Chan S. R. Computer-assisted cognitive-behavior therapy and mobile apps for depression and anxiety. Current Psychiatry Reports, 2019, 21(7). https://doi.org/10.1007/s11920-019-1031-2

76. Carlbring P., Andersson G., Cuijpers P., Riper H., Hedman-Lagerlöf E. Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: an updated systematic review and meta-analysis. Cognitive Behaviour Therapy, 2018, 47(1): 1–18. https://doi.org/10.1080/16506073.2017.1401115

77. Brenninkmeijer V., Lagerveld S. E., Blonk R. W. B., Schaufeli W. B., Wijngaards-de Meij L. D. N. V. Predicting the effectiveness of work-focused CBT for common mental disorders: the influence of baseline self-efficacy, depression and anxiety. Journal of Occupational Rehabilitation, 2019, 29(1): 31–41. https://doi.org/10.1007/s10926-018-9760-3

78. Trevors G., Duffy M. C. Correcting COVID-19 misconceptions requires caution. Educational Researcher, 2020, 49(7): 538–542. https://doi.org/10.3102/0013189X20953825

79. Zhang Y., Guo B., Ding Y., Liu J., Qiu C., Liu S., Yu Z. Investigation of the determinants for misinformation correction effectiveness on social media during COVID-19 pandemic. Information Processing & Management, 2022, 59(3). https://doi.org/10.1016/j.ipm.2022.102935

80. Vetrova T. V., Podolskaia V.-A. V. Features of psychological state of persons suffering disease caused by action of coronaviral infection of new type (Covid-19) and ways of correction of detected negative changes. Proceedings of scientific conferences of the National Research Institute of Humanities "National Development": Proc. All-Russian (National) Sci. Conf., St. Petersburg, 11–13 Oct 2021. St. Petersburg: HNRI National development, 2021, 71–78. (In Russ.) https://doi.org/10.37539/OCT321.2021.21.35.004

81. Kostenko E. V., Eneeva M. A., Petrova L. V., Pogonchenkova I. V. Cognitive disorders and neuropsychiatric sequellae associated with Covid-19. Doсtor.Ru, 2021, 20(5), 6–12. (In Russ.) https://doi.org/10.31550/1727-2378-2021-20-5-6-12